|Min SIP Amount||Not Supported|
|NAV||₹13.68 (20 Apr 2021)|
|Fund Started||10 Oct 2014|
|Fund Size||₹52 Cr|
|Axis Bank Ltd.||Financial||Equity||9.9%|
|Tech Mahindra Ltd.||Technology||Equity||9.0%|
|Bharti Airtel Ltd.||Communication||Equity||8.6%|
|SBI Life Insurance Company Ltd.||Financial||Equity||8.3%|
|Gland Pharma Ltd.||Healthcare||Equity||7.0%|
|ICICI Bank Ltd.||Financial||Equity||6.9%|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||6.5%|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||3.9%|
|Kotak Mahindra Bank Ltd.||Financial||Equity||3.6%|
ICICI Prudential Growth Fund Series 3 Direct IDCW is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 10 Oct 2014. S Naren, Ashwin Jain is the Current Fund Manager of ICICI Prudential Growth Fund Series 3 Direct IDCW fund.The fund currently has an Asset Under Management(AUM) of ₹52 Cr and the Latest NAV as of 20 Apr 2021 is ₹13.68.
The ICICI Prudential Growth Fund Series 3 Direct IDCW is rated Very High risk.
The scheme seeks to provide capital appreciation by investing in a well diversified portfolio of equity and equity related securities.